.jpg) |
Dr. Glenn Wilson (left), professor and chair of cell biology and
neuroscience, with Dr. Mark Gillespie (right), professor and chair of
pharmacology.
|
The company, Exscien, was awarded $54,000, more than half of the $100,000 in funding awarded to the three winners.
Exscien, led by Steve and Christine Cumbie, focuses its efforts on developing a new drug to prevent and reverse acute lung injury.
Dr. Mark Gillespie, professor and chair of pharmacology and a member of the Center for Lung Biology at the University of South Alabama College of Medicine, is one of the partners in the company. The USA College of Medicine is collaborating with Exscien in an effort to rapidly develop treatments.
To read the full article featured in the Press-Register, click here. To read more about the biotech company and its affiliation with the USA College of Medicine, click here.
